J&J announces USFDA approval of IMBRUVICA

Company |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more

Natco Pharma invests Rs 100Cr in agrochemical space

Company |  News | 0 Comment | 28 Jan, 2019

Natco Pharma Limited has initiated work on green-field manufacturing facilities for producing Niche Agrichemical products in the Nellore District of Andhra Pradesh. These facilities will ma...Read more

USFDA completes inspection at Lupin’s Indore facility

Company |  News | 0 Comment | 28 Jan, 2019

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Pithampur Unit-2 (Indore) facility. The inspection was carried out between January 14 and Januar...Read more

Cipla receives approval for pfizer's Depo-Provera

Company |  News | 0 Comment | 28 Jan, 2019

Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United S...Read more

Basilea announces collaboration with Roche

Company |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche to explore a combination of Basilea's derazantinib and Roche's PD-L1-...Read more

Dr. Reddy's announces the launch of sedation drug in US

Company |  News | 0 Comment | 25 Jan, 2019

Dr. Reddy’s Laboratories Ltd. has announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN (propofol) Injectable Emulsion, USP, ...Read more

PHARMASEAL launches clinical trial platform for integrated governance

Company |  News | 0 Comment | 24 Jan, 2019

PHARMASEAL provides clinical trial management platform and governance solutions to enter the market, has launched Engility™ CTMS, the first product to be released from its Engility B2...Read more

Glenmark receives tentative ANDA approval for generic QUDEXY

Company |  News | 0 Comment | 24 Jan, 2019

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules, 25...Read more

FDA accepts Roche’s supplemental biologics license application for Tecentriq

Company |  News | 0 Comment | 23 Jan, 2019

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Tecentriq® (atezolizumab) in c...Read more

Glenmark receives tentative ANDA approval for generic Zytiga

Company |  News | 0 Comment | 23 Jan, 2019

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Abiraterone Acetate Tablets USP, 250 mg,...Read more

Sun Pharma transfers domestic formulations distribution to subsidiary

Company |  News | 0 Comment | 22 Jan, 2019

Sun Pharma, India's top pharmaceutical company has announced some changes and clarifications. It has decided to transfer its domestic formulations distribution from Aditya Medisales Ltd to ...Read more

Zydus gets tentative USFDA approval for acid reflux capsules

Company |  News | 0 Comment | 22 Jan, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The company has received the tentative...Read more

GSK plans to appoint new Chairman

Company |  News | 0 Comment | 22 Jan, 2019

GlaxoSmithKline plc (GSK), a science-led global healthcare company, has announced that Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman and ...Read more

Lilly reports results of ANNOUNCE

Company |  News | 0 Comment | 21 Jan, 2019

Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combination with doxorubicin in patients with advanced or metastatic soft tis...Read more

AffordPlan remarks 300% growth in maternity patient base

Company |  News | 0 Comment | 21 Jan, 2019

AffordPlan, a first-of-its-kind financial technology platform that enables healthcare savings for individuals, registers an annual growth of 300 percent in maternity patient care. Set ...Read more

LupinLife to launch Corcal Bone & Beauty at LFW

Company |  News | 0 Comment | 21 Jan, 2019

LupinLife’s Corcal Bone & Beauty announces a collaboration with Lakme Fashion Week to celebrate #beautifullystrong women across India at the upcoming Lakme Fas...Read more

Sesderma to launch Dr. Serrano Clinics in India

Company |  News | 2 Comment | 18 Jan, 2019

Sesderma India recently organised a press conference in New Delhi. The company which is a subsidiary of Sesderma Laboratories headquartered in Valencia, Spain announce its plan of launching...Read more

Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

Company |  News | 0 Comment | 18 Jan, 2019

Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also...Read more